Saxagliptin PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Saxagliptin PCD pharma franchise company offering 4 WHO-GMP certified formulations available in Tablets. We provide monopoly-based distribution rights to pharma entrepreneurs and distributors across India, backed by DCGI-approved quality and a reliable supply chain.
What is Saxagliptin?
Saxagliptin is a DPP-4 inhibitor that increases incretin hormone levels to raise insulin release and lower glucose production, improving blood-sugar control in type 2 diabetes. It is a prescription-only medicine and should be used only under qualified medical supervision. Read the compound profile on PubChem.
Available Saxagliptin Formulations
Cafoli Lifecare offers 4 Saxagliptin formulations for franchise partners. Available forms: Tablets. Every batch is manufactured at WHO-GMP certified facilities and supplied with full regulatory documentation. Pricing is shared on request.
Therapeutic Applications
Saxagliptin is used to improve blood-sugar control in adults with type 2 diabetes mellitus, alongside diet and exercise. It is prescribed mainly by diabetologists, endocrinologists and general physicians.
Why Saxagliptin is a High-Potential Molecule for Distributors
Diabetes is one of the fastest-growing chronic conditions in India and DPP-4 inhibitors are taken daily for years, giving Saxagliptin a large, expanding and highly repeatable patient base.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, attractive promotional inputs and dedicated marketing support to a growing network of 1000+ franchise partners across India. Our focus on quality and on-time supply makes us a preferred Saxagliptin franchise partner.
References
- PubChem: Saxagliptin
- PubMed research on Saxagliptin
Our formulations of Saxagliptin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: